Login
Login     |     Register     |     Recover Username/Password

General Investing

Recovery in DRAM & NAND Flash To Boost Spending In 2012

May 29, 2012

A pickup in spending is expected in the second half of the year in the memory segment of the semiconductor capital equipment space for companies levered to developments in DRAM and NAND flash, says Patrick Ho, Vice President at Stifel Nicolaus & Co., Inc.

“Overall, we should see a pickup in NAND flash in the second half of the year, and that should trickle down positively for capex spending in that customer segment,” he said. “I think what I characterize as what I call a wild card is DRAM. I think DRAM is beginning to show some signs of recovery.”

Ho recommends Lam Research Corporation (LRCX) in terms companies that will benefit from a recovery in memory. When looking at the group as a whole, he likes Lam Research based on, not only near-term industry fundamentals, but also longer term due to the acquisition of Novellus Systems, Inc.

“Plus, by their acquisition of Novellus, I do believe that it opens up opportunities with Intel that Lam Research never had before this deal. So both near term and long term, I do like that name, it’s one of my preferred names at this time,” Ho said.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now